Metabolism and biological activity of 1,25(OH)2D2 and its metabolites in a chronic myelogenous leukemia cell line, rwleu-4
- 1 September 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (9) , 1873-1878
- https://doi.org/10.1016/s0960-894x(00)80123-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Steroid hormone actions at the plasma membrane: Induced calcium uptake and exocytotic eventsMolecular and Cellular Endocrinology, 1991
- On the Mechanisms for the Selective Action of Vitamin D Analogs*Endocrinology, 1991
- Effects of novel 26,27-dialkyl analogs of 1α,25-dihydroxyvitamin D3 on differentiation-inducing activity of human promyelocytic leukemia (HL-60) cells in serum-supplemented or serum-free cultureSteroids, 1991
- Differentiation‐related regulation of 1,25 dihydroxy vitamin D3 receptor mRNA in human leukaemia cells HL‐60Cell Proliferation, 1991
- Characteristics of the 25-hydroxyvitamin D3- and 1,25-dihydroxyvitamin D3-24-hydroxylase(s) from HL-60 cellsArchives of Biochemistry and Biophysics, 1991
- Effect of retinoids and 1,25(OH)2 vitamin D3 bound to their plasma transport proteins on growth and differentiation of HL-60 cellsScandinavian Journal of Clinical and Laboratory Investigation, 1990
- Metabolism of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 and its sensitivity to ketoconazole in 1α,25-dihydroxyvitamin D3-differentiated HL60 cellsJournal of Molecular Endocrinology, 1989
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- 1,25(OH) 2 ‐Vitamin D 3 receptors: gene regulation and genetic circuitryThe FASEB Journal, 1988
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987